[Form 4] Bristol-Myers Squibb Co. Insider Trading Activity

Rhea-AI Filing Summary

On 1 July 2025, Oxford Industries, Inc. (ticker: OXM) filed a Form 4 disclosing that non-employee director Dennis M. Love received an equity grant on 30 June 2025.

• Type of security: 6,086 restricted common shares issued under the company’s Long-Term Stock Incentive Plan as part of Mr. Love’s annual director retainer.
• Transaction code: “A” (acquisition) at a stated price of $0, indicating a grant rather than an open-market purchase.
• Post-transaction ownership: Mr. Love now directly holds 22,628 common shares.

No derivative securities were involved and no additional transactions were reported. The filing reflects routine director compensation and results in minimal dilution to existing shareholders.

Insights

Securities Analyst

TL;DR: Routine director stock grant; neutral impact on valuation.

The filing records issuance of 6,086 restricted shares (≈0.04% of outstanding) to director Dennis Love as part of standard board compensation. Because the shares were granted at no cost and represent an immaterial fraction of Oxford Industries’ share count, the market impact is expected to be negligible. The award modestly increases insider ownership, offering slight alignment with shareholders but does not signal management’s view of valuation, as it was not an open-market purchase. Overall, this is a standard periodic disclosure rather than a catalyst.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YALE PHYLLIS R

(Last) (First) (Middle)

BRISTOL-MYERS SQUIBB COMPANY

ROUTE 206 AND PROVINCE LINE ROAD

(Street)

PRINCETON NJ 08543

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	06/30/2025		A		756.103		(1)	(1)	Common Stock, $0.10 par value	756.103	$0	36,447.723(2)	D

Explanation of Responses:

1. Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

2. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Remarks:

EXHIBIT LIST: EX-24 Exhibit 24 - Phyllis R. Yale, GRAPHIC Exhibit 24 - Phyllis R. Yale

	/s/ Lisa A. Atkins, attorney-in-fact for Phyllis R. Yale	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Oxford Industries (OXM) disclose in its latest Form 4?

OXM reported that director Dennis M. Love was granted 6,086 restricted common shares on 30 June 2025 as part of his annual retainer.

How many shares did director Dennis M. Love acquire?

He acquired 6,086 restricted shares of Oxford Industries common stock.

At what price were the restricted shares granted?

The shares were issued at $0 because they are part of a director compensation grant.

What is Dennis M. Love’s total ownership after the transaction?

Following the grant, Mr. Love owns 22,628 shares of OXM common stock directly.

Does this Form 4 indicate insider buying confidence?

Not necessarily; the shares were awarded as compensation, not purchased on the open market, so it provides limited insight into valuation sentiment.